Company Overview of Cerexa, Inc.
Cerexa, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective therapies for the treatment of antibiotic-resistant infections. It provides Ceftaroline AcetateCeftaroline, an injectable cephalosporin that is used for the treatment of bacterial infections caused by gram-positive and gram-negative pathogens. The company was founded in 2005 and is based in Alameda, California.
2100 Franklin Street
Oakland, CA 94612
Founded in 2005
Key Executives for Cerexa, Inc.
Similar Private Companies By Industry
|Diabetica Research Solutions, Incorporated||United States|
|Innophos Nutrition, Inc.||United States|
|LifeTein LLC||United States|
|Capsugel Manufacturing, Inc.||United States|
|AmeReGen BioPharmaceuticals Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Cerexa, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.